Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously

Journal of Travel Medicine

Volumn 6, Issue 2, 1999, Pages 134-136

  Naraporn, Nipa ^b   Khawplod, Pakamatz ^b   Limsuwan, Kornvika ^b   Thipkong, Penmas ^b   Herzog, Christian ^b   Glueck, Reinhard ^b   Tantawichien, Terapong ^b   Wilde, Henry ^a  

^a QUEEN SAOVABHA MEMORIAL INSTITUTE   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; RABIES VACCINE;

ARTICLE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INTRADERMAL DRUG ADMINISTRATION; RABIES; VACCINATION;

EID: 0033012290     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1999.tb00844.x     Document Type: Article

References (8)

1. World Health Organization. Expert Committee Rabies. Technical Report Technical report series 824. WHO: Geneva 1992.
2. World Health Organization. Recommendations on rabies postexposure treatment, the correct technique of intradermal immunization against rabies. Document: WHO/EMC/Zoo. 96.6. WHO: Geneva 1996.
3. Threanhart O, Kranzfelder E, Hillebrandt M, et al. Long term humoral and cellular immunity after vaccination with cell culture rabies vaccine in man. Clin Immunol Immunopathol 1994; 71:287-292.
4. Khawplod P, Wilde H, Yenmuang W, et al. Immune response to tissue culture rabies vaccine in subjects who had previous postexposure treatment with semple or sucking mouse brain vaccine. Vaccine 1996;14:1549-1552.
5. Kositprapa C, Limsuwan K, Wilde H, et al. Immune response to simulated postexposure rabies booster vaccination in volunteers who had preexposure vaccination. Clin Infect Diseases 1997; 25:614-616.
6. Smith J, Yager PA, Baer GM. A rapid reproducible test for detection of rabies neutralizing antibodies. In: Meslin FX, Kaplan MM, Koprowski H, eds. Laboratory techniques in rabies. WHO 1996; Geneva: 181-192.
7. Khawplod P, Wilde H, Glueck R, et al. Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO -approved intradermal postexposure regimen. Clin Infect Dis 1995; 20:646-651.
8. Swanson MC, Rosanoff E, Gurwith M, et al. IgE and IgG antibodies to betapropriolactone and human serum albumin associated with urticarial reactions in rabies vaccine. J Infect Dis 1987; 155:909-913.